'Profitable, High-Growth' CellRight Bulks Up Tissue Regenix's Ortho Biz
Executive Summary
In acquiring CellRight Technologies, a young but already profitable US company specializing in regenerative bone technologies, UK regenerative medicine firm Tissue Regenix will significantly bulk up its portfolio and accelerate its global commercial growth plans.